In a time where individualized medication therapy is the standard, there are few places in medicine where we find near agreement on a treatment. One notable exception is Metformin being the cornerstone for oral therapy in treating type 2 diabetes. Metformin’s ability to lower A1C, low incidence of hypoglycemia and protective effects on the heart make it the first line recommendation in most clinical practice guidelines. But many people with diabetes need more than one medication to get to their A1C goal. With numerous classes of drugs used to treat diabetes, how is the second drug chosen? Why does one person get a prescription for one medication, while someone else might be given something completely different? Prescribers treating patients with diabetes have more choices than ever before. While this seems like it would be an advantage (and it clearly is!), the decision-making process for the second, third, and any […]
